Haemonetics Corporation · NYSE:HAE
North Peak Capital Management, LLC's stake in Haemonetics Corporation fell below 5% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 13, 2026
North Peak Capital Management, LLC's stake in Haemonetics Corporation fell below 5%, 0 shares, as a passive investor on Mar 31, 2026. Filed May 13, 2026 (Schedule 13G/A).
- Stake
- 0%
- Shares
- 0
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 8 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| North Peak Capital Management, LLC | 0% | 0 |
| North Peak Capital GP, LLC | 0% | 0 |
| North Peak Capital Partners, LP | 0% | 0 |
| North Peak Capital Partners II, LP | 0% | 0 |
| North Peak Capital Alpha Fund, LP | 0% | 0 |
| North Peak Capital Ultra Fund, LP | 0% | 0 |
| Michael Kevin Kahan | 0% | 0 |
| Jeremy Steven Kahan | 0% | 0 |
Source
Related
- Haemonetics Corporation
- North Peak Capital Management, LLC
- Haemonetics Corporation shareholders
- Schedule 13G · North Peak Capital Management, LLC · Mar 3, 2026
- Schedule 13G/A · AQR Capital Management LLC · Aug 12, 2026
- Form 4 · Abernathy Robert E · Jul 28, 2026
- Form 4 · Madaus Martin D · Jul 28, 2026
- Form 4 · Zane Ellen M · Jul 28, 2026
- Form 4 · Pomeroy Claire · Jul 28, 2026